Ganzeboom KS,Mairuhu G, Reitsma JB, LinzerM,Wieling W, Van Dijk N. Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35–60 years. Journal of cardiovascular electrophysiology. 2006;17(11):1172-6.

Kenny RA, Bhangu J, King-Kallimanis BL. Epidemiology of syncope/collapse in younger and older Western patient populations. Progress in cardiovascular diseases. 2013;55(4):357-63.

Pfister R, Tan D, Thekkanal J, Hellmich M, Schneider CA. Predictors of elevated NT-pro-BNP in cardiovascular patients without acute heart failure. International journal of cardiology. 2009;131(2):277-80.

Costantino G, SolbiatiM, Pisano G, Furlan R. NT-pro-BNP for differential diagnosis in patients with syncope. International

journal of cardiology. 2009;137(3):298-9.

Tada H, Ito S, Shinbo G, Tadokoro K, Ito I, Hashimoto T, et al. Significance and utility of plasma brain natriuretic peptide concentrations in patients with idiopathic ventricular arrhythmias. Pacing and clinical electrophysiology. 2006;29(12):1395-403.

Wojtowicz J, Szczepanski W, Bogdan A, Baran M, Szczurak J, Bossowski A. Natriuretic peptides in the evaluation of syncope in children and adolescents. Scandinavian journal of clinical and laboratory investigation. 2014;74(4):301-5.

Zhang Q, Jin H, Qi J, Yan H,Du J.Diagnostic value of serum brain natriuretic peptide in syncope in children and adolescents.

Acta Paediatrica. 2013;102(5).

Tanimoto K, Yukiiri K, Mizushige K, Takagi Y, Masugata H, Shinomiya K, et al. Usefulness of brain natriuretic peptide as a marker for separating cardiac and noncardiac causes of syncope. American Journal of Cardiology. 2004;93(2):228-30.